179 related articles for article (PubMed ID: 19029489)
1. Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats.
Yi F; Xia M; Li N; Zhang C; Tang L; Li PL
Hypertension; 2009 Jan; 53(1):90-6. PubMed ID: 19029489
[TBL] [Abstract][Full Text] [Related]
2. Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia.
Conley SM; Abais-Battad JM; Yuan X; Zhang Q; Boini KM; Li PL
Free Radic Biol Med; 2017 May; 106():236-244. PubMed ID: 28193546
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of homocysteine-induced Rac1/NADPH oxidase activation in mesangial cells: role of guanine nucleotide exchange factor Vav2.
Yi F; Chen QZ; Jin S; Li PL
Cell Physiol Biochem; 2007; 20(6):909-18. PubMed ID: 17982273
[TBL] [Abstract][Full Text] [Related]
4. NMDA receptor-mediated activation of NADPH oxidase and glomerulosclerosis in hyperhomocysteinemic rats.
Zhang C; Yi F; Xia M; Boini KM; Zhu Q; Laperle LA; Abais JM; Brimson CA; Li PL
Antioxid Redox Signal; 2010 Oct; 13(7):975-86. PubMed ID: 20406136
[TBL] [Abstract][Full Text] [Related]
5. VAV2, a guanine nucleotide exchange factor for Rac1, regulates glucose-stimulated insulin secretion in pancreatic beta cells.
Veluthakal R; Tunduguru R; Arora DK; Sidarala V; Syeda K; Vlaar CP; Thurmond DC; Kowluru A
Diabetologia; 2015 Nov; 58(11):2573-81. PubMed ID: 26224100
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats.
Yi F; Zhang AY; Li N; Muh RW; Fillet M; Renert AF; Li PL
Kidney Int; 2006 Jul; 70(1):88-96. PubMed ID: 16688115
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney.
Hwang SY; Siow YL; Au-Yeung KK; House J; O K
Am J Physiol Renal Physiol; 2011 Jan; 300(1):F189-98. PubMed ID: 20980407
[TBL] [Abstract][Full Text] [Related]
8. Functional Regulation of an Oxidative Stress Mediator, Rac1, in Diabetic Retinopathy.
Mohammad G; Duraisamy AJ; Kowluru A; Kowluru RA
Mol Neurobiol; 2019 Dec; 56(12):8643-8655. PubMed ID: 31300985
[TBL] [Abstract][Full Text] [Related]
9. NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia.
Abais JM; Zhang C; Xia M; Liu Q; Gehr TW; Boini KM; Li PL
Antioxid Redox Signal; 2013 May; 18(13):1537-48. PubMed ID: 23088210
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine enhances TIMP-1 expression and cell proliferation associated with NADH oxidase in rat mesangial cells.
Yang ZZ; Zou AP
Kidney Int; 2003 Mar; 63(3):1012-20. PubMed ID: 12631082
[TBL] [Abstract][Full Text] [Related]
11. Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation.
Zhang Q; Conley SM; Li G; Yuan X; Li PL
Kidney Blood Press Res; 2019; 44(4):513-532. PubMed ID: 31266025
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats.
Edirimanne VE; Woo CW; Siow YL; Pierce GN; Xie JY; O K
Can J Physiol Pharmacol; 2007 Dec; 85(12):1236-47. PubMed ID: 18066125
[TBL] [Abstract][Full Text] [Related]
13. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.
Liu BP; Burridge K
Mol Cell Biol; 2000 Oct; 20(19):7160-9. PubMed ID: 10982832
[TBL] [Abstract][Full Text] [Related]
14. Contribution of NADPH oxidase to membrane CD38 internalization and activation in coronary arterial myocytes.
Xu M; Li XX; Ritter JK; Abais JM; Zhang Y; Li PL
PLoS One; 2013; 8(8):e71212. PubMed ID: 23940720
[TBL] [Abstract][Full Text] [Related]
15. Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.
Heo J; Thapar R; Campbell SL
Biochemistry; 2005 May; 44(17):6573-85. PubMed ID: 15850391
[TBL] [Abstract][Full Text] [Related]
16. Vav2 is an activator of Cdc42, Rac1, and RhoA.
Abe K; Rossman KL; Liu B; Ritola KD; Chiang D; Campbell SL; Burridge K; Der CJ
J Biol Chem; 2000 Apr; 275(14):10141-9. PubMed ID: 10744696
[TBL] [Abstract][Full Text] [Related]
17. Stimulus-dependent regulation of the phagocyte NADPH oxidase by a VAV1, Rac1, and PAK1 signaling axis.
Roepstorff K; Rasmussen I; Sawada M; Cudre-Maroux C; Salmon P; Bokoch G; van Deurs B; Vilhardt F
J Biol Chem; 2008 Mar; 283(12):7983-93. PubMed ID: 18160398
[TBL] [Abstract][Full Text] [Related]
18. Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity.
Havel LS; Kline ER; Salgueiro AM; Marcus AI
Oncogene; 2015 Apr; 34(15):1979-90. PubMed ID: 24858039
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia.
Zhang C; Xia M; Boini KM; Li CX; Abais JM; Li XX; Laperle LA; Li PL
Pflugers Arch; 2011 Sep; 462(3):455-67. PubMed ID: 21647593
[TBL] [Abstract][Full Text] [Related]
20. Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis.
Hunter SG; Zhuang G; Brantley-Sieders D; Swat W; Cowan CW; Chen J
Mol Cell Biol; 2006 Jul; 26(13):4830-42. PubMed ID: 16782872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
